Glycine → {[1-(4-Fluoro-benzyl)-4-hydroxy-1H-pyrrolo[2,3-c]pyridine-5-carbonyl]-amino}-acetic acid
Reaction equation
C(O[C:4]([C:6]1[C:7]([OH:23])=[C:8]2[CH:14]=[CH:13][N:12]([CH2:15][C:16]3[CH:21]=[CH:20][C:19]([F:22])=[CH:18][CH:17]=3)[C:9]2=[CH:10][N:11]=1)=[O:5])C.[NH2:24][CH2:25][C:26]([OH:28])=[O:27].C[O-].[Na+].CO>>[F:22][C:19]1[CH:20]=[CH:21][C:16]([CH2:15][N:12]2[C:9]3=[CH:10][N:11]=[C:6]([C:4]([NH:24][CH2:25][C:26]([OH:28])=[O:27])=[O:5])[C:7]([OH:23])=[C:8]3[CH:14]=[CH:13]2)=[CH:17][CH:18]=1Participants
4
Procedure
Prepared in analogy to that of Example 1(e) from 1-(4-fluoro-benzyl)-4-hydroxy-1H-pyrrolo[2,3-c]pyridine-5-carboxylic acid ethyl ester, glycine and NaOMe/HOMe. The title compound, ESI MS (m/z): 344 (M+H)+.
Sources & evidence
- ORD record
- ord-aee63f5876d04249b1008fe596ddbb14
- Source dataset
- uspto-grants-2010_04
- Patent number
- US07696223B2
Reaction notes
Loading…